Bio-Rad Laboratories (BIO) Deferred Taxes (2015 - 2017)

Bio-Rad Laboratories' (BIO) quarterly Deferred Taxes came in at -$5.3 million in Q3 2017, down 142.66% year-on-year from $12.5 million in Q3 2016, and down 284.83% on a QoQ basis from $2.9 million in Q2 2017.

Bio-Rad Laboratories (BIO) Deferred Taxes (2015 - 2017) Analysis & Trends

Bio-Rad Laboratories (BIO) has 3 years of Deferred Taxes data on file, last reported at -$5.3 million in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -33.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -8.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -351.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -9.40 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 7.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 51.51 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Bio-Rad Laboratories 8.53 Bn 6.97 Bn 309.40 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2017 -5.35 Mn
Jun 30, 2017 2.89 Mn
Mar 31, 2017 163,000.00
Sep 30, 2016 12.54 Mn
Jun 30, 2016 -666,000.00
Mar 31, 2016 -3.39 Mn
Sep 30, 2015 -2.73 Mn